tiprankstipranks
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market

Ascletis Pharma, Inc. (1672) Ownership - Who Owns Ascletis Pharma, Inc.?

Compare
2 Followers

Ascletis Pharma, Inc. (1672) Ownership Overview

0.10%0.02%99.88%
0.02% ETFs
99.88% Public Companies and
Individual Investors
The ownership structure of Ascletis Pharma, Inc. (HK:1672) stock is a mix of institutional, retail, and individual investors. , and 99.88% is owned by Public Companies and Individual Investors.
The ownership structure of Ascletis Pharma, Inc. (HK:1672) stock is a mix of institutional, retail, and individual investors. Approximately 99.90% of the company’s stock is owned by Institutional Investors, 0.10% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
940,000Institution0.10%485,040
186,000Institution0.02%95,976

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
940,000Institution0.10%485,040

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
185,000Institution0.02%96,044
1,000Institution<0.01%519

FAQ

Who Owns Ascletis Pharma, Inc. (HK:1672)?
Currently, no data Available
What percentage of Ascletis Pharma, Inc. (HK:1672) stock is held by institutional investors?
Currently, no data Available
What percentage of Ascletis Pharma, Inc. (HK:1672) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.88% of Ascletis Pharma, Inc. (HK:1672) stock is held by retail investors.
    Who owns the most shares of Ascletis Pharma, Inc. (HK:1672)?
    DFA INVESTMENT DIMENSIONS GROUP INC owns the most shares of Ascletis Pharma, Inc. (HK:1672).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis